Key result
Family history of VTE linked to ~5-fold higher VT risk in adolescent offspring.
Why the study?
Differences in age-specific and sex-specific familial risks for pulmonary embolism, venous thrombosis of the lower limbs, and other venous thromboembolism manifestations were not well characterized.
Does a family history of venous thromboembolism increase the age-specific and sex-specific risk of VTE manifestations in relatives?
Observational (n=45,362)
Does a family history of venous thromboembolism increase the age-specific and sex-specific risk of VTE manifestations in relatives?
A family history of VTE is a significant, likely genetic, risk indicator for various manifestations of VTE in both sexes, particularly in individuals under 70 years of age, and is useful for clinical risk assessment.
Answers are grounded in this paper and cite their sources.
Familial aggregation across VTE subtypes supports shared genetic susceptibility; leaves open whether family history should alter clinical risk stratification.
This nationwide study aimed to determine whether differences exist in age-specific and sex-specific familial risks for pulmonary embolism (PE), venous thrombosis of the lower limbs (VT) and other forms of venous thromboembolism (OVTE) among offspring, siblings and spouses of affected individuals. The Swedish Multi-Generation Register was linked to the Hospital Discharge Register data for the period 1987-2007. Standardised incidence ratios (SIRs) were calculated for individuals whose relatives were hospitalised for venous thromboembolism (VTE), as determined by the International Classification of Diseases (ICD), and those whose relatives were unaffected by VTE. The total number of hospitalised VTE patients was 45,362. All VTE patients were categorised as PE, VT or OVTE according to ICD at first hospitalisation. For example, the parental SIRs for PE, VT and OVTE in offspring at age 10-19 years were 2.89 (95% CI 1.48-5.06), 4.99 (95% CI 3.22-6.10) and 3.89 (95% CI 2.51-5.75), respectively. The low spousal risks of PE (1.08; 95% CI 1.02-1.13), VT (1.06; 95% CI 1.011.12) and OVTE (1.07; 95% CI 1.00-1.15) suggest the familial risks to be largely genetic. In both men and women, familial relative risks were increased for all the different manifestations of VTE with the exception of those older than 70 years. Familial history is a risk indicator in both sexes, and is potentially useful for clinical risk assessment for the different manifestations of VTE.
No takes yet. Share an insight, caveat, or question.
Li et al. (2011) conducted an observational in Venous thromboembolism (PE, VT, OVTE) (n=45,362). Familial history of VTE vs. Relatives unaffected by VTE was evaluated on Standardised incidence ratios (SIRs) for VTE manifestations (SIR 4.99, 95% CI 3.22-6.10). Familial history of VTE increased the risk for all VTE manifestations, suggesting a genetic component.
Synapse has enriched 10 related papers. Consider them for comparative context: